Browse > Article
http://dx.doi.org/10.6114/jkood.2016.29.4.061

Effects of Torilis japonica Extract on DNCB-induced Contact Dermatitis in BALB/c Mice  

Lee, Kyou-Young (Dept. of Oriental Opthalmology and Otolaryngology and Dermatology, College of Korean Medicine, Sangji University)
Song, Eun-Hye (Dept. of Pharmacology, College of Korean Medicine, Sangji University)
Hong, Chul-Hee (Dept. of Oriental Opthalmology and Otolaryngology and Dermatology, College of Korean Medicine, Sangji University)
Publication Information
The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology / v.29, no.4, 2016 , pp. 61-77 More about this Journal
Keywords
Torilis japonica (TJ); Type 2 helper T (Th2); Atopic dermatitis (AD); Allergic contact dermatitis (ACD);
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Urb M, Sheppard DC. The role of mast cells in the defence against pathogens. PLoS pathogens. 2012;8(4):e1002619.   DOI
2 Weller K, Foitzik K, Paus R, Syska W, Maurer M. Mast cells are required for normal healing of skin wounds in mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2006;20(13):2366-8.   DOI
3 Amin K. The role of mast cells in allergic inflammation. Respiratory medicine. 2012;106(1):9-14.   DOI
4 Kouro T, Takatsu K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. International immunology. 2009;21(12):1303-9.   DOI
5 Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy. 2004;59(6):561-70.   DOI
6 Onoue A, Kabashima K, Kobayashi M, Mori T, Tokura Y. Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin. Experimental dermatology. 2009;18(12):1036-43.   DOI
7 Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature immunology. 2002;3(7):673-80.   DOI
8 Takai T, Chen X, Xie Y, Vu AT, Le TA, Kinoshita H, et al. TSLP expression induced via Toll-like receptor pathways in human keratinocytes. Methods in enzymology. 2014;535:371-87.
9 Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A, et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. The Journal of experimental medicine. 2005;202(4):541-9.   DOI
10 Correale CE, Walker C, Murphy L, Craig TJ. Atopic dermatitis: a review of diagnosis and treatment. American family physician. 1999;60(4):1191-8, 1209-10.
11 Herman SM, Vender RB. Antihistamines in the treatment of dermatitis. Journal of cutaneous medicine and surgery. 2003;7(6):467-73.   DOI
12 Stanbury RM, Graham EM. Systemic corticosteroid therapy--side effects and their management. The British journal of ophthalmology. 1998;82(6):704-8.   DOI
13 Segal AO, Ellis AK, Kim HL. CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology. 2013;9(1):24.   DOI
14 Carr WW. Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations. Paediatric drugs. 2013;15(4):303-10.   DOI
15 Kim GT, Lee SH, Kim YM. Torilis japonica extract, a new potential EMT suppressor agent by regulation of EGFR signaling pathways. International journal of oncology. 2014;45(4):1673-9.   DOI
16 Kim SM, Kim TH, Lee EB. Anti-inflammatory activities of Torilis japonica fruit. The Korean Society of Pharmacognosy. 1998;29(4):384-90.
17 Kim MS, Lee YM, Moon EJ, Kim SE, Lee JJ, Kim KW. Anti-angiogenic activity of torilin, a sesquiterpene compound isolated from Torilis japonica. International journal of cancer. 2000;87(2):269-75.   DOI
18 Kim MS, Baek JH, Park MT, Sohn TK, Kim SE, Lee JJ, et al. Anti-invasive activity of torilin, a sesquiterpene compound isolated from Torilis japonica. Oncology reports. 2001;8(2):359-64.
19 Cho WI, Choi JB, Lee K, Chung MS, Pyun YR. Antimicrobial activity of torilin isolated from Torilis japonica fruit against Bacillus subtilis. Journal of food science. 2008;73(2):37-46.
20 Sone K, Yamamoto-Sawamura T, Kuwahara S, Nishijima K, Ohno T, Aoyama H, et al. Changes of estrous cycles with aging in female F344/n rats. Experimental animals / Japanese Association for Laboratory Animal Science. 2007;56(2):139-48.   DOI
21 Park SJ, Lee HA, Kim JW, Lee BS, Kim EJ. Platycodon grandiflorus alleviates DNCBinduced atopy-like dermatitis in NC/Nga mice. Indian journal of pharmacology. 2012;44(4):469-74.   DOI
22 Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature. 2008;454(7203):445-54.   DOI
23 Petersen LJ, Mosbech H, Skov PS. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. The Journal of allergy and clinical immunology. 1996;97(2):672-9.   DOI
24 Gschwandtner M, Mildner M, Mlitz V, Gruber F, Eckhart L, Werfel T, et al. Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model. Allergy. 2013;68(1):37-47.   DOI
25 Minami K, Kamei C. A chronic model for evaluating the itching associated with allergic conjunctivitis in rats. International immunopharmacology. 2004;4(1):101-8.   DOI
26 Guttman-Yassky E, Dhingra N, Leung DY. New era of biologic therapeutics in atopic dermatitis. Expert opinion on biological therapy. 2013;13(4):549-61.   DOI
27 Hamelmann E, Gelfand EW. IL-5-induced airway eosinophilia--the key to asthma? Immunological reviews. 2001;179:182-91.   DOI
28 Corren J. Anti-interleukin-5 antibody therapy in asthma and allergies. Current opinion in allergy and clinical immunology. 2011;11(6):565-70.   DOI
29 Stein ML, Villanueva JM, Buckmeier BK, Yamada Y, Filipovich AH, Assa'ad AH, et al. Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels. The Journal of allergy and clinical immunology. 2008;121(6):1473-83.   DOI
30 Oh MH, Oh SY, Yu J, Myers AC, Leonard WJ, Liu YJ, et al. IL-13 induces skin fibrosis in atopic dermatitis by thymic stromal lymphopoietin. Journal of immunology. 2011;186(12):7232-42.   DOI
31 Gittler JK, Kreuger JG, Guttman-Yassky E. Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis. J Allergy Clin Immunol. 2013;131:300-13.   DOI
32 Jung M, Lee TH, Oh HJ, Kim H, Son Y, Lee EH, et al. Inhibitory effect of 5,6-dihydroergosteol- glucoside on atopic dermatitis-like skin lesions via suppression of NF-kappaB and STAT activation. Journal of dermatological science. 2015;79(3):252-61.   DOI
33 Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. Journal of dermatological science. 2013;70(1):3-11.   DOI
34 Fonacier LS, Dreskin SC, Leung DY. Allergic skin diseases. The Journal of allergy and clinical immunology. 2010;125(2 Suppl 2):S138-49.   DOI
35 Liu FT, Goodarzi H, Chen HY. IgE, mast cells, and eosinophils in atopic dermatitis. Clinical reviews in allergy & immunology. 2011;41(3):298-310.   DOI
36 Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nature immunology. 2008;9(11):1215-23.   DOI
37 Lindstedt KA, Kovanen PT. Isolation of mast cell granules. Current protocols in cell biology. 2006;Chapter 3(Unit 3):16.
38 Tazawa T, Sugiura H, Sugiura Y, Uehara M. Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis. Archives of dermatological research. 2004;295(11):459-64.   DOI
39 Greaves MW. Antihistamines in dermatology. Skin pharmacology and physiology. 2005;18(5):220-9.   DOI
40 Imaizumi A, Kawakami T, Murakami F, Soma Y, Mizoguchi M. Effective treatment of pruritus in atopic dermatitis using H1 antihistamines (second-generation antihistamines): changes in blood histamine and tryptase levels. Journal of dermatological science. 2003;33(1):23-9.   DOI
41 Yamazaki F, Aragane Y, Maeda A, Matsushita K, Ueno K, Yudate T, et al. Overactivation of IL-4-induced activator protein-1 in atopic dermatitis. Journal of dermatological science. 2002;28(3):227-33.   DOI
42 Ackerman SJ, Bochner BS. Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. Immunology and allergy clinics of North America. 2007;27(3):357-75.   DOI
43 Corren J. Inhibition of interleukin-5 for the treatment of eosinophilic diseases. Discovery medicine. 2012;13(71):305-12.
44 Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY. In vivo expression of IL-12 and IL-13 in atopic dermatitis. The Journal of allergy and clinical immunology. 1996;98(1):225-31.   DOI
45 Wang YH, Liu YJ. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2009;39(6):798-806.   DOI
46 Moran TP, Vickery BP. The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch. Pediatrics. 2014;134 suppl 3:S160-1.
47 Shimada Y, Takehara K, Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. Journal of dermatological science. 2004;34(3):201-8.   DOI
48 Alysandratos KD, Angelidou A, Vasiadi M, Zhang B, Kalogeromitros D, Katsarou-Katsari A, et al. Increased affected skin gene expression and serum levels of thymic stromal lymphopoietin in atopic dermatitis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2010;105(5):403-4.   DOI
49 Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. The Journal of clinical investigation. 1999;104(8):1097-1105.   DOI
50 Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. Journal of dermatological science. 2006;43(2):75-84.   DOI
51 Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activationregulated chemokine level is closely related with disease activity. The Journal of allergy and clinical immunology. 2001;107(3):535-41.   DOI
52 College of Oriental Medicine Compilation Committee of Herbalogy. Herbalogy. Seoul:Younglimsa. 2006:630-1.
53 Park SM. The documentary examining of gynecologic symptoms and medical substances of fumigation treatment. Master's Thesis Kyung-San University. 2002:57.
54 Sin MG. Clinical Herbalogy. Younglimsa. 1994:197, 271, 590.
55 Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. The Journal of clinical investigation. 2004;113(5):651-7.   DOI
56 Kimber L, Basketter DA, Gerberick GF, Dearman RJ. Allergic contact dermatitis. International immunopharmacology. 2002;2(2-3):201-11.   DOI
57 Sung YY, Yang WK, Lee AY, Kim DS, Nho KJ, Kim YS, et al. Topical application of an ethanol extract prepared from illicium verum suppresses atopic dermatitis in NC/Nga mice. J Ethnopharmacol. 2012;144:151-9.   DOI
58 Takeda K, Gelfand EW. Mouse models of allergic diseases. Curr Opin Immunol. 2009;21:660-5.   DOI
59 Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003;361(9352):151-60.   DOI
60 Nutten S. Atopic dermatitis: global epidemiology and risk factors. Annals of nutrition & metabolism. 2015;66 suppl 1:8-16.   DOI
61 Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunological reviews. 2011;242(1):233-46.   DOI
62 Wang IJ, Guo YL, Weng HJ, Hsieh WS, Chuang YL, Lin SJ, et al. Environmental risk factors for early infantile atopic dermatitis. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2007;18(5):441-7.   DOI
63 Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cellattracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. The Journal of allergy and clinical immunology. 2004;113(2):334-40.   DOI
64 Sher A, Coffman RL. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annual review of immunology. 1992;10:385-409.   DOI
65 Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. The Journal of allergy and clinical immunology. 2004;113(3):395-400.   DOI
66 Akdis CA, Akdis M, Simon D, Dibbert B, Weber M, Gratzl S, et al. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. The Journal of investigative dermatology. 1999;113(4):628-34.   DOI
67 Hasbold J, Hong JS, Kehry MR, Hodgkin PD. Integrating signals from IFN-gamma and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE and IgG2a. Journal of immunology. 1999;163(8):4175-81.
68 Izuhara K, Shirakawa T. Signal transduction via the interleukin-4 receptor and its correlation with atopy. International journal of molecular medicine. 1999;3(1):3-10.
69 Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nature medicine. 2012;18(5):693-704.   DOI
70 Choi JE, Park BK, Jin MR. Anti-inflammatory and Antioxidant Effects of Water Extracts of Sasangja-tang(SSJ) and Gami-sasangja-tang (GSJ). Collection of dissertations Institute of Oriental Medicine Daejeon University. 2015;23(2):7-8.
71 Koo BS, Hwang EI, So SH, Lee SK, Han GH, Kim NM. Effect of Torilis Fructus on Procollagen Biosynthesis and Activity of Matrix Metalloproteinase-I(MMP-1) in Human Dermal Fibroblast. Kor. J. Pharmacogn. 2007;38(4):350.